Ultra-High Resolution Mass Spectrometer for Biomedical Research

用于生物医学研究的超高分辨率质谱仪

• 批准号: 7839335
• 负责人: Joseph A Loo
• 金额: $ 270.99万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-04-15 至 2011-10-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7839335
• 关键词: Aging; Alzheimer' s Disease; Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Arts; Biological Markers; Biomedical Research; Cells; Detection; Devices; Disease; Dissociation; Electron Transport; Electrons; Fourier transform ion cyclotron resonance; Funding; Health; Human; Huntington Disease; Institution; Ions; Ligands; Malignant Neoplasms; Measurement; Membrane Proteins; Methods; Molecular; Neurodegenerative Disorders; Parkinson Disease; Peptide Sequence Determination; Peptides; Phosphorylation; Post-Translational Protein Processing; Proteins; Research; Research Personnel; Research Support; Resolution; Scientist; System; Training; base; human disease; improved; instrument; instrumentation; magnetic field; mass spectrometer; outcome forecast; protein structure; public health relevance; research study; small molecule; tandem mass spectrometry; ultra high resolution

DESCRIPTION (provided by applicant): A high-magnetic field, ultra-high resolution Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometer with capabilities for enhanced top-down protein sequencing and metabolite detection is requested. This instrument will be a vital component to support the research aims of over 11 NIH-funded projects. The studies involve a variety of protein structure-related research, including the determination of protein-protein and protein-ligand interactions, protein phosphorylation, membrane protein structure, and the identification of protein biomarkers for disease detection and prognosis. The research will impact a range of human health issues, including aging, neurodegenerative diseases, such as Huntington's disease, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS), and cancer. The ultra-high resolution FT-ICR mass spectrometer will be capable of sub-parts-per-million to parts-per-billion mass measurement accuracy for intact peptides/proteins and product ions derived from tandem mass spectrometry (MS/MS) experiments, and small molecule metabolite identification. It will have capabilities for multistage MS-n experiments (n greater than 2) to be conducted in the ICR trapping/detection device, thus permitting advanced top-down analysis using infrared multiphoton dissociation (IRMPD) and electron capture dissociation (ECD) for efficient ion activation and dissociation in the ICR cell. Electron transfer dissociation (ETD) will be available as an alternative dissociation method. Both ETD and ECD greatly improve the ability to dissociate intact proteins to derive complete sequence information, as well as holding the promise of direct detection of post-translational modifications. The instrument will be a centerpiece and will be supported and administered by the Molecular Instrumentation Center at UCLA, and it will serve researchers from across the institution and nearby institutions. PUBLIC HEALTH RELEVANCE: The new instrumentation will benefit a wide range of biomedical studies. The high sensitivity and high resolution capabilities of the system will provide a new means to identify the mechanistic basis of a number of human diseases, such as neurodegenerative disorders, and it may be used to identify new protein markers of cancer. The availability of this new, state-of-the-art mass spectrometer will require highly trained scientists to be hired and maintained for its operational use.

描述（由申请人提供）：高磁场，超高分辨率傅立叶转化离子回旋共振（FT-ICR）质谱仪，具有增强自上而下蛋白质测序和代谢物检测的能力。该工具将是支持11个NIH资助项目的研究目标的重要组成部分。该研究涉及各种与蛋白质结构相关的研究，包括确定蛋白质 - 蛋白质和蛋白质 - 配体相互作用，蛋白质磷酸化，膜蛋白结构以及鉴定蛋白质生物标志物以疾病检测和预后。这项研究将影响一系列人类健康问题，包括衰老，神经退行性疾病，例如亨廷顿氏病，阿尔茨海默氏病，帕金森氏病和肌萎缩性侧面硬化症（ALS）和癌症。超高分辨率FT-ICR质谱仪将能够为完整肽/蛋白质和串联质谱法（MS/MS）实验和小分子代谢物鉴定的完整肽/蛋白质和产物离子提供每千万次至每十亿美元的质量测量精度。它将具有多阶段MS-N实验（N大于2）的功能，因此可以在ICR捕获/检测设备中进行，从而允许使用红外多光子分离（IRMPD）和电子捕获分离（ECD）进行高级自上而下分析，以实现ICR细胞中有效的离子激活和分离。电子转移解离（ETD）将作为替代解离法提供。 ETD和ECD都大大提高了分离完整蛋白以得出完整序列信息的能力，并有望直接检测到翻译后修饰。该仪器将是一个核心，并将得到UCLA分子仪器中心的支持和管理，它将为整个机构和附近机构的研究人员提供服务。 公共卫生相关性：新仪器将使广泛的生物医学研究受益。该系统的高灵敏度和高分辨率能力将提供一种新的手段，以识别许多人类疾病的机械基础，例如神经退行性疾病，并且可以用来识别癌症的新蛋白质标志物。这种新的，最先进的质谱仪的可用性将要求训练有素的科学家被录用和维护以供其运营使用。